• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- Steps move Boston lab closer to BSL-4 work

Shiloh

Editor, Senior Moderator
Source: http://www.cidrap.umn.edu/news-perspective/2014/05/steps-move-boston-lab-closer-bsl-4-work


Steps move Boston lab closer to BSL-4 work
Filed Under:
Biosecurity Issues; Bioterrorism
Lisa Schnirring | Staff Writer | CIDRAP News
|
May 15, 2014


Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), completed in 2008 but yet to begin work on the most dangerous pathogens, cleared two more obstacles yesterday when the Boston city council struck down a proposed ban on the work and a state court turned back a challenge to a risk assessment.

Following a long debate a month ago, the Boston city council voted eight to five against a proposed ban on biosafety level 4 (BSL-4) work at the lab, according to a report today BU Today, the campus newspaper.

Over the past several years the lab has faced a host of litigation hurdles from neighborhood and other groups who oppose work on the pathogens at the lab over safety concerns in the urban area where the facility is located.

Also, the project has been mired in controversy over gaps in a risk assessment conducted by the National Institutes of Health (NIH). In 2011, however, the National Academies of Sciences (NAS) reviewed a revision of the NIH's risk assessment, finding vast improvements.

In the other action, yesterday the Massachusetts Superior Court rejected a challenge to the NIH's risk assessment, according to the BU Today report. In October a federal court took a similar action, ruling that the NIH's final risk assessment adequately analyzes the safety risks. The risk assessment looked at several scenarios, including containment failures and terrorist acts.

The lab still needs approval from the Boston Public Health Commission before it can begin BSL-4 research.

During all the legal challenges, the lab has done only BSL-2 work. Last September a federal court cleared the way for BSL-3 work to begin, and scientists are getting ready to start tuberculosis research at the lab, according to BU Today.

See also:

May 15 BU Today story

Oct 1, 2013, CIDRAP News scan "Boston BSL-4 lab clears judicial hurdle"

NEIDL Web site
 
Back
Top Bottom